FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21557611000001101: Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Dec 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71554801000001117 Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80121801000001119 Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Is a Generic Dermovate-NN ointment true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has active ingredient Clobetasol propionate true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has active ingredient Nystatin true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP false Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has specific active ingredient Clobetasol propionate true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has specific active ingredient Nystatin true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) 30 gram Has AMP True Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (A A H Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start